等待開盤 11-05 09:30:00 美东时间
-0.030
-0.63%
AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investment firm focused on disruptive technologies, today announced definitive terms to acquire Blockchain Wire, the
今天 19:23
AlphaTON Capital Corp, a leading investment firm specializing in disruptive technologies, has announced the acquisition of an additional 300,000 TON Coin to expand its digital asset treasury. As a Nasdaq-listed company (Ticker: ATON), AlphaTON is focused on developing the Telegram ecosystem, managing a strategic reserve of TON tokens, and driving sustainable returns for shareholders through a comprehensive M&A and treasury strategy. The company's...
今天 01:37
The latest update is out from TRATON SE ( ($DE:8TRA) ). TRATON GROUP reported a...
10-29 15:30
AlphaTON Capital will invest significantly in high-performance GPUs and data center infrastructure to support Cocoon, a decentralized AI network announced by Telegram founder Pavel Durov. Cocoon enables secure and private AI inference by compensating GPU owners with TON cryptocurrency. AlphaTON's investment aims to provide the computational capacity needed for Telegram and other major applications, highlighting the convergence of blockchain, AI, ...
10-29 14:46
AlphaTON Capital's CEO, Brittany Kaiser, will speak at the Future of Money, Governance, and the Law summit on October 30, 2025, at Capitol Hill. Organized by the Government Blockchain Association and The Edge Of Company, the event focuses on digital assets, governance, and regulation. Kaiser, known for her work in digital rights and ethical Web3 innovation, will discuss responsible innovation, digital identity, and tokenized ecosystems empowering...
10-27 12:10
Cyncado Therapeutics presented data showing that TT-4, a selective A2B receptor antagonist, exhibits direct anti-tumor effects in epithelial and non-epithelioid mesothelioma models. In combination with anti-PD-1, TT-4 achieved >90% tumor growth inhibition in vivo, and as monotherapy, it outperformed anti-PD-1 alone. The study also demonstrated reduced tumor PD-L1 expression correlating with decreased pCREB, supporting TT-4's potential for immune ...
10-27 12:00
Cyncado Therapeutics presented new data at the AACR-NCI-EORTC conference in Boston, showing that their selective A2B receptor antagonist, TT-4, demonstrates direct anti-tumor activity in mesothelioma models, reduces tumor PD-L1 and pCREB levels, and exhibits strong monotherapy activity with additional benefits when combined with anti-PD-1. TT-4 is on track for first-patient dosing in Q1 2026. The study highlights the tumor-intrinsic mechanism of ...
10-25 16:30
The latest announcement is out from AlphaTON Capital ( ($ATON) ). AlphaTON Capi...
10-23 21:28
AlphaTON Capital ( ($ATON) ) just unveiled an announcement. AlphaTON Capital Co...
10-22 21:27
AlphaTON Capital joins the Blockchain Game Alliance (BGA) and plans to acquire 51% of GAMEE, a leading Telegram-first gaming platform, to strengthen its Telegram/TON gaming strategy. With Telegram surpassing 1 billion monthly active users, AlphaTON aims to expand access to instant, mobile-first games via Telegram mini-apps and TON wallets. The company offers growth capital, launch support, and community marketing to BGA studios, aligning with the...
10-22 16:45